Matches in Nanopublications for { ?s ?p "[These binding sites for basic helix-loop-helix transcription factors are recognized by a nuclear protein from the melanoma cell line PSM, most likely MITF, as its exogenous delivery could activate the promoter in non-melanoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP828949.RAjA5WlvJ_xYy6Fj4KfUWgO1TiQcnhfSIXAZkw16m88C0130_assertion description "[These binding sites for basic helix-loop-helix transcription factors are recognized by a nuclear protein from the melanoma cell line PSM, most likely MITF, as its exogenous delivery could activate the promoter in non-melanoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP828949.RAjA5WlvJ_xYy6Fj4KfUWgO1TiQcnhfSIXAZkw16m88C0130_provenance.
- NP419083.RAgWa_i4tbMx2l63OQ7gegWZl92EWxywVQ0v1IuNRcGao130_assertion description "[These binding sites for basic helix-loop-helix transcription factors are recognized by a nuclear protein from the melanoma cell line PSM, most likely MITF, as its exogenous delivery could activate the promoter in non-melanoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419083.RAgWa_i4tbMx2l63OQ7gegWZl92EWxywVQ0v1IuNRcGao130_provenance.
- NP786137.RAJ3c6BYWKyVTiw8C0Wh8_qv4gFgv7uG8Vbynra2PBXRU130_assertion description "[These binding sites for basic helix-loop-helix transcription factors are recognized by a nuclear protein from the melanoma cell line PSM, most likely MITF, as its exogenous delivery could activate the promoter in non-melanoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP786137.RAJ3c6BYWKyVTiw8C0Wh8_qv4gFgv7uG8Vbynra2PBXRU130_provenance.
- NP419084.RA-JE9WWbQV0M1R7UIGZoc4M4hLbOCyDrpkXT7pw4iYN4130_assertion description "[These binding sites for basic helix-loop-helix transcription factors are recognized by a nuclear protein from the melanoma cell line PSM, most likely MITF, as its exogenous delivery could activate the promoter in non-melanoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419084.RA-JE9WWbQV0M1R7UIGZoc4M4hLbOCyDrpkXT7pw4iYN4130_provenance.